Literature DB >> 23538417

ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice.

C Tiveron1, L Fasulo, S Capsoni, F Malerba, S Marinelli, F Paoletti, S Piccinin, R Scardigli, G Amato, R Brandi, P Capelli, S D'Aguanno, F Florenzano, F La Regina, A Lecci, A Manca, G Meli, L Pistillo, N Berretta, R Nisticò, F Pavone, A Cattaneo.   

Abstract

ProNGF, the precursor of mature nerve growth factor (NGF), is the most abundant form of NGF in the brain. ProNGF and mature NGF differ significantly in their receptor interaction properties and in their bioactivity. ProNGF increases markedly in the cortex of Alzheimer's disease (AD) brains and proNGF\NGF imbalance has been postulated to play a role in neurodegeneration. However, a direct proof for a causal link between increased proNGF and AD neurodegeneration is lacking. In order to evaluate the consequences of increased levels of proNGF in the postnatal brain, transgenic mice expressing a furin cleavage-resistant form of proNGF, under the control of the neuron-specific mouse Thy1.2 promoter, were derived and characterized. Different transgenic lines displayed a phenotypic gradient of neurodegenerative severity features. We focused the analysis on the two lines TgproNGF#3 and TgproNGF#72, which shared learning and memory impairments in behavioral tests, cholinergic deficit and increased Aβ-peptide immunoreactivity. In addition, TgproNGF#3 mice developed Aβ oligomer immunoreactivity, as well as late diffuse astrocytosis. Both TgproNGF lines also display electrophysiological alterations related to spontaneous epileptic-like events. The results provide direct evidence that alterations in the proNGF/NGF balance in the adult brain can be an upstream driver of neurodegeneration, contributing to a circular loop linking alterations of proNGF/NGF equilibrium to excitatory/inhibitory synaptic imbalance and amyloid precursor protein (APP) dysmetabolism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23538417      PMCID: PMC3705592          DOI: 10.1038/cdd.2013.22

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  59 in total

Review 1.  On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease.

Authors:  Simona Capsoni; Antonino Cattaneo
Journal:  Cell Mol Neurobiol       Date:  2006-08-31       Impact factor: 5.046

2.  Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.

Authors:  Julie A Harris; Nino Devidze; Laure Verret; Kaitlyn Ho; Brian Halabisky; Myo T Thwin; Daniel Kim; Patricia Hamto; Iris Lo; Gui-Qiu Yu; Jorge J Palop; Eliezer Masliah; Lennart Mucke
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

Review 3.  Astrocytes in Alzheimer's disease.

Authors:  Alexei Verkhratsky; Markel Olabarria; Harun N Noristani; Chia-Yu Yeh; Jose Julio Rodriguez
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

4.  The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies.

Authors:  A Rattenholl; H Lilie; A Grossmann; A Stern; E Schwarz; R Rudolph
Journal:  Eur J Biochem       Date:  2001-06

5.  Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.

Authors:  L Holcomb; M N Gordon; E McGowan; X Yu; S Benkovic; P Jantzen; K Wright; I Saad; R Mueller; D Morgan; S Sanders; C Zehr; K O'Campo; J Hardy; C M Prada; C Eckman; S Younkin; K Hsiao; K Duff
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

6.  Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.

Authors:  P Ciana; G G Braliou; F G Demay; M von Lindern; D Barettino; H Beug; H G Stunnenberg
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

7.  Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Authors:  Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

8.  Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins.

Authors:  Marta Volosin; Wenyu Song; Ramiro D Almeida; David R Kaplan; Barbara L Hempstead; Wilma J Friedman
Journal:  J Neurosci       Date:  2006-07-19       Impact factor: 6.709

9.  Cholinergic Degeneration and Alterations in the TrkA and p75NTR Balance as a Result of Pro-NGF Injection into Aged Rats.

Authors:  Ashley M Fortress; Mona Buhusi; Kris L Helke; Ann-Charlotte E Granholm
Journal:  J Aging Res       Date:  2011-07-11

10.  Alzheimer's disease: synaptic dysfunction and Abeta.

Authors:  Ganesh M Shankar; Dominic M Walsh
Journal:  Mol Neurodegener       Date:  2009-11-23       Impact factor: 14.195

View more
  28 in total

1.  Imbalance of the Nerve Growth Factor and Its Precursor: Implication in Diabetic Retinopathy.

Authors:  Riyaz Mohamed; Azza B El-Remessy
Journal:  J Clin Exp Ophthalmol       Date:  2015-10-25

2.  Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Yang Du; Huan-Tong Wu; Xiao-Yan Qin; Chang Cao; Yi Liu; Zong-Ze Cao; Yong Cheng
Journal:  J Mol Neurosci       Date:  2018-06-28       Impact factor: 3.444

Review 3.  Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance.

Authors:  Noralyn Basco Mañucat-Tan; Khalil Saadipour; Yan-Jiang Wang; Larisa Bobrovskaya; Xin-Fu Zhou
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

4.  Differential regulation of macrophage phenotype by mature and pro-nerve growth factor.

Authors:  Kimberly S Williams; Deirdre A Killebrew; Gillian P Clary; Jaimie A Seawell; Rick B Meeker
Journal:  J Neuroimmunol       Date:  2015-05-16       Impact factor: 3.478

Review 5.  Targeting the Cation-Chloride Co-Transporter NKCC1 to Re-Establish GABAergic Inhibition and an Appropriate Excitatory/Inhibitory Balance in Selective Neuronal Circuits: A Novel Approach for the Treatment of Alzheimer's Disease.

Authors:  Simona Capsoni; Ivan Arisi; Francesca Malerba; Mara D'Onofrio; Antonino Cattaneo; Enrico Cherubini
Journal:  Brain Sci       Date:  2022-06-15

6.  A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, α2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo.

Authors:  Pablo F Barcelona; H Uri Saragovi
Journal:  Mol Cell Biol       Date:  2015-07-27       Impact factor: 4.272

7.  Nerve growth factor metabolic dysfunction in Down's syndrome brains.

Authors:  M Florencia Iulita; Sonia Do Carmo; Alison K Ower; Ashley M Fortress; Lisi Flores Aguilar; Michael Hanna; Thomas Wisniewski; Ann-Charlotte Granholm; Mona Buhusi; Jorge Busciglio; A Claudio Cuello
Journal:  Brain       Date:  2014-02-11       Impact factor: 13.501

8.  Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications.

Authors:  Francesca Malerba; Francesca Paoletti; Bruno Bruni Ercole; Serena Materazzi; Romina Nassini; Elisabetta Coppi; Riccardo Patacchini; Simona Capsoni; Doriano Lamba; Antonino Cattaneo
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

9.  Grape Seed Proanthocyanidin Extract Ameliorates Diabetic Bladder Dysfunction via the Activation of the Nrf2 Pathway.

Authors:  Shouzhen Chen; Yaofeng Zhu; Zhifeng Liu; Zhaoyun Gao; Baoying Li; Dongqing Zhang; Zhaocun Zhang; Xuewen Jiang; Zhengfang Liu; Lingquan Meng; Yue Yang; Benkang Shi
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

Review 10.  How Does p73 Cause Neuronal Defects?

Authors:  Maria Victoria Niklison-Chirou; Richard Killick; Richard A Knight; Pierluigi Nicotera; Gerry Melino; Massimiliano Agostini
Journal:  Mol Neurobiol       Date:  2015-08-13       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.